Published online before print September 6, 2007

This Article Full Text (Rapid PDF) All Versions of this Article: ajpath.2007.070201v1 171/4/1291    most recent Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Song, Y. J. C. Articles by Jensen, P. H. Search for Related Content PubMed PubMed Citation Articles by Song, Y. J. C. Articles by Jensen, P. H.

Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.070201

Accepted for publication July 3, 2007.

Article

p25 Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy

Yun Ju C. Song^*, Ditte M.S. Lundvig, Yue Huang^*, Wei Ping Gai, Peter C. Blumbergs, Peter Højrup^¶, Daniel Otzen^||, Glenda M. Halliday^*, and Poul H. Jensen^@

From the Prince of Wales Medical Research Institute,* Randwick, New South Wales, Australia; the Departments of Human Physiology, and Medicine, Flinders University School of Medicine, Adelaide, South Australia, Australia; the Institute of Medical Biochemistry, University of Aarhus, Aarhus, Denmark; the Institute of Molecular Biology,^¶ University of Southern Denmark, Odense, Denmark; and the Department of Life Science,^|| Aalborg University, Aalborg, Denmark

^@ To whom correspondence should be addressed. E-mail: phj{at}biokemi.au.dk.

	Abstract

p25 is an oligodendroglial protein that can induce aggregation of -synuclein and accumulates in oligodendroglial cell bodies containing fibrillized -synuclein in the neurodegenerative disease multiple system atrophy (MSA). We demonstrate biochemically that p25 is a constituent of myelin and a high-affinity ligand for myelin basic protein (MBP), and in situ immunohistochemistry revealed that MBP and p25 colocalize in myelin in normal human brains. Analysis of MSA cases reveals dramatic changes in p25 and MBP throughout the course of the disease. In situ immunohistochemistry revealed a cellular redistribution of p25 immunoreactivity from the myelin to the oligodendroglial cell soma, with no overall change in p25 protein concentration using immunoblotting. Concomitantly, an 80% reduction in the concentration of full-length MBP protein was revealed by immunoblotting along with the presence of immunoreactivity for MBP degradation products in oligodendroglia. The oligodendroglial cell bodies in MSA displayed an enlargement along with the relocalization of p25, and this was enhanced after the deposition of -synuclein in the glial cytoplasmic inclusions. Overall, the data indicate that changes in the cellular interactions between MBP and p25 occur early in MSA and contribute to abnormalities in myelin and subsequent -synuclein aggregation and the ensuing neuronal degeneration that characterizes this disease.